Hendrik Treede, MD

Director
University Heart and Vascular Center Mainz
Mainz, Rheinland-Pfalz, Germany

Prof. Dr. Hendrik Treede is a board certified cardiac surgeon and Director of the Department of Cardiovascular Surgery at the University Heart and Vascular Center Mainz, Germany. After finishing his medical studies at Hamburg University he underwent residency and attending positions at University Hospital Munich Großhadern and University Heart Center Hamburg. 2015 - 2018 he was Director of the Mid-German Heart Center in Halle (Saale), 2018 - 2021 Director of the Department of Cardiac Surgery at the University Heart Center Bonn, since 2021 he is holding this position at the University Hospital Mainz. Prof. Treede is member of numerous scientific societies and an active clinical and experimental researcher in structural heart disease. His main scientific focus lies in interventional and minimally-invasive heart valve surgery. Prof. Treede has published more than 200 manuscripts in peer-reviewed journals.

Presentation(s):

• Fully Endoscopic Beating Heart Tricuspid Valve Repair in Patients Unsuitable for TEER CardioValve – TR

  Sunday, February 26, 2023
  4:11 PM – 4:19 PM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• First in Human Experience With a Novel Transfemoral Tricuspid Valve Replacement System (Topaz Valve)

  Sunday, February 26, 2023
  5:07 PM – 5:15 PM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• Panel Discussion: How Should We Proceed With Tricuspid Valve Interventions and When Should We Intervene?

  Sunday, February 26, 2023
  5:45 PM – 6:00 PM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• TAVR in Small Anatomies, Mitigating the Risk of Coronary Occlusion with a New Low Profile Valve Achieving Comissural Alignment (JenaValve)

  Monday, February 27, 2023
  2:49 PM – 2:57 PM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Treatment of Aortic Insufficiency | The Next Frontier

  Monday, February 27, 2023
  3:47 PM – 4:10 PM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• LATE-BREAKING TRIALS | SESSION FOUR

  Tuesday, February 28, 2023
  8:00 AM – 9:00 AM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• JenaValve Technology and Clinical Update

  Tuesday, February 28, 2023
  10:10 AM – 10:18 AM ET

  Disclosure(s): Boston Scientific Corporation: Advisor (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); JenaValve Technology Inc: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing); TriCares: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Shareholder (Ongoing)

• Emerging New Devices for Percutaneous Transcatheter Tricuspid Transcatheter Repair

  Tuesday, February 28, 2023
  11:34 AM – 11:42 AM ET

  Disclosure information not submitted.